The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / The New Front Line of STI Diagnosis
Omics Precision medicine Research and Innovations Molecular Pathology

The New Front Line of STI Diagnosis

Point-of-care and at-home tests are expanding access while creating new challenges for reporting and public health surveillance

By Nikolina Babic, Sheldon Campbell, Kate Crawford 11/18/2026 Discussion 5 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

5 Key Takeaways
  • 1

    Point-of-care STI tests provide results near the site of care, typically within minutes to an hour, enabling clinical decisions during the same visit.

  • 2

    FDA-cleared, CLIA-waived molecular assays can detect chlamydia and gonorrhea in about 20 minutes, with accuracy approaching laboratory-based testing.

  • 3

    Same-visit results can reduce dependence on follow-up, which is especially important for people facing barriers to care or at increased risk of being lost to follow-up.

  • 4

    Point-of-care testing may reduce empiric treatment and unnecessary antibiotic exposure, while supporting antimicrobial stewardship.

  • 5

    Implementation challenges include cost, operational complexity, specimen-type restrictions, workflow demands, and the need for staff training and quality oversight.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Nikolina Babic

Nikolina Babic is Board-certified clinical chemist and Professor of Pathology and Laboratory Medicine, Medical University of South Carolina.

More Articles by Nikolina Babic

Sheldon Campbell

Sheldon Campbell is Professor of Laboratory Medicine, Yale School of Medicine, and Director of Clinical Laboratories, VA Connecticut Healthcare System.

More Articles by Sheldon Campbell

Kate Crawford

Kate Crawford is Acting Assistant Professor, Department of Laboratory Medicine and Pathology, University of Washington.

More Articles by Kate Crawford

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.